The Angel Fund for ALS Research Mission
The Angel Fund for ALS Research (Angel Fund, Inc). is an independent 501(c)(3) nonprofit organization dedicated to supporting research into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Founded in 1997, The Angel Fund focuses on funding scientific investigations at UMass Chan Medical School in Worcester, MA.
Mission and Impact
The Angel Fund’s mission is to raise funds through events, campaigns, foundation grants, and community outreach to support ALS research aimed at finding the cause, treatment, and cure for the disease . Our organization operates with minimal overhead—no rent, utility bills, or high-paid executives—allowing over 90% of its expenditures to directly fund research .
The Angel Fund has made significant contributions to ALS research, including a $750,000 donation in 2024 to support the work of Dr. Robert H. Brown Jr. and his team at UMass Chan Medical School . Dr. Brown is renowned for discovering the first gene associated with hereditary ALS and leading the first gene therapy clinical trial for the disease
ALS Research Team
Robert H. Brown Jr., DPhil, MD
Director of Neurotherapeutics
Umass Chan Medical School
Dr. Daryl A. Bosco, PhD
Professor and Associate Vice Chair of Neurology Research
Umass Chan Medical School
Dr. John Landers
UMass Chan Medical School
Scientist
Desiree Baron, PhD
Research Scientist, Sr.
Landers Lab
Catherine L. Douthwright, PhD, CCRP
Assistant Professor
Neuromuscular Clinical Research
Debra Cameron
Research Associate III
Landers & Bosco Labs
Nils Henninger, M.D., Ph.D., Dr. med., FANA, FWSO
Associate Professor of
Neurology and Psychiatry
Dr.Katharina Elisabeth (Karin) Meijboom
Postdoctoral Researcher
UMass Medical School
Jonathan Jung
Graduate Student
Bosco Lab
Finding A Cure
For ALS
Faces of ALS
